{"text":"Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was tested for plasma inhibition of Angiotensin I converting enzyme activity in the conscious rat. Expressed as Inhibition of AI pressor response at 6 hr at a dose of 12.1 mg\/kg po","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effective dose required to produce an increase in dP\/dt by 1500 mmHg\/s from that of the control in the anesthetized cats.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"D2 receptor functional activity was measured through reversal of quinpirole inhibited, forskolin stimulated cAMP production from whole cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect on the activity of elastase was determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Functional ERalpha receptor activity in transcriptional activation assay in MCF-7 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]GABA from rat brain Gamma-aminobutyric acid receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Concentration inhibiting radiolabeled spermidine transport in L1210 cells.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of glycogen synthesis in rat skeletal muscle L6 cells (inactive)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Evaluated for survival time of P388 Leukemia implanted female CDF1 Mice at a dose of 25 mg\/kg","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vivo anticonvulsant activity in male albino mice using the maximal electroshock (MES) test after intraperitoneal administration; value ranges from 85.7-151","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Rauscher leukemia virus in female BALB\/c mice. Compound is administered perorally at 125 mg\/kg for 5 days a week for 4 weeks (exp 1); treated\/control= 46.8\/46.0","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards cloned human muscarinic acetylcholine receptor M4 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against P338 leukemia cells measured as toxic level at 3.12 mg\/kg, ip optimal dose on days 1-5 in mice","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards peroxisome proliferator activated receptor gamma (PPAR gamma); weakly active","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for its binding affinity to Poly (dA-dT) by using ethidium displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic Poly (dA-dT); ND = no data","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Apparent binding constant was determined by ethidium displacement assay in poly (dG-dC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic Poly (dG-dC); ND = no data","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic poly (dG-dC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Apparent DNA binding constant to Poly (dG-dC) was determined using an ethidium displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]PDBu from protein kinase C beta C1b domain","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Dissociation constant against stem loop IIB region of RRE-response element RNA was reported","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Concentration required to decrease 25% of blood pressure in rat; ED25 not reached at 1.0 mg\/kg iv","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Dose-dependent protective activity at 10 mg\/kg (po, b.i.d.) on cartilage damage in hind paws of CIA-rats","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"inhibition of the growth of renal cancer(UO-31) cell line","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of aggregation of human gel-filtered platelets measured by light transmittance method at 37 degrees C.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition against human pancreas carcinoma cell line (BxPC-3); (NT = Not tested)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against A549 cell line","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro binding affinity towards cloned human 5-HT6 receptor using [3H]5-carboximidotryptamine as radioligand: nd=Not determined","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against methicillin-resistant Staphylococcus aureus B42876","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Effect on ratio of total cholesterol to HDL cholesterol in lean Wistar rat at 70 mg\/kg\/day relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Escherichia coli MC4100 assessed as inhibition zone at >2 mg\/mL","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of HER2 at 1 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at 2.2 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as circular dichrosim at 10 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA at 4 uM in phosphate buffer of pH 7.4 by UV-vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to negatively supercoiled Escherichia coli pBR322 DNA assessed as DNA intercalation at 10 to 20 uM at pH 8 after 30 mins by DNA unwinding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to F10T hairpin duplex DNA assessed as change in melting temperature at 1 uM by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of PKCalpha","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human cytoplasmic ribosomal RNA A-site assessed as thermal stability at compound\/RNA ratio of 5 by UV melting profile method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MDA-MB-435 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at concentration of 0.1 [compound]\/[DNA]","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of radioligand from adrenergic alpha2A receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]estradiol from human recombinant estrogen receptor alpha by radiometric assay relative to estradiol","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of gentamycin from Escherichia coli 16S ribosomal 27-nucleotide A-site RNA by water Logsy NMR spectroscopy based competitive displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of gentamycin from Escherichia coli 16S ribosomal 27-nucleotide A-site RNA by water Logsy NMR spectroscopy based noncompetitive binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 3 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 0.1 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DA12:DAc12 oligomer sequence of bulge DNA by fluorescence quenching","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in sodium cacodylate buffer assessed as melting temperature at compound\/DNA ratio 0.2 at pH 7","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in sodium cacodylate buffer assessed as melting temperature at compound\/DNA ratio 0.3 at pH 7","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Clostridium difficile CD5 expressing tet(W) gene","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding constant for PIM1 kinase domain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli pUC19 DNA assessed as form 1 DNA level at 0.320 mM after 4.95 hrs by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli pUC19 DNA assessed as form 1 DNA level at 0.320 mM after 25.35 hrs by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative activity against human CCRF-CEM cells at 10 uM assessed as cell growth inhibition relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human NCI-H23 cells assessed as cell growth at 0.1 uM after 1 to 11 days by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Aurora A phosphorylation in human A549 cells at 0.15 to 5 uM after 1 hr by Western blot analysis in presence of nocodazole and proteasome inhibitor MG132","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to poly dA-poly dT RNA in citric acid buffer at pH 5 by fluorescence titration assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae with Ile449Val, Asn526Lys substitutions in penicillin-binding protein 3 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Ratio of acyclovir EC50 to compound EC50 for HSV 2 infected in african green monkey Vero cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of human MAPKAP-K3 at 10 uM after 60 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of p110alpha\/p85alpha at 10 uM after 60 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of EC50 for HIV1 TM harboring L10I\/K14R\/R41K\/M46L\/I54V\/L63P\/A71V\/V82A\/L90M\/I93L in protease encoding region to EC50 for HIV1 ERS104pre","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Trypanocidal activity against Trypanosoma brucei brucei 667 infected in mouse assessed as average day of relapse of trypanosomal infection at 25 mg\/kg, ip BID for 14 days","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]AVP from human V2 receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 2-amino purine labelled SAM2 riboswitch aptamer assessed as change in fluorescence at 5 mM to 10 mM at pH 8.3 by fluorescence binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]Iloprost from human prostanoid IP receptor expressed in CHO cells after 60 mins by liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-telomeric quadruplex 5'-GGGTTAGGGTTAGGGTTAGGG-3' assessed as the intensity ratio of all complex ions to the sum of all G-quadruplex and complex ions at 20 uM by ESI mass spectroscopy relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of ethidium bromide from salmon sperm DNA at 1 uM by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric G-quadruplex DNA 5'-d(AOxodGGTTAGGGTTAGGGTTAGGGTGTT) at 1 to 10 uM by CD titration method in presence of 100 mM of KCl","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex in second binding event at 480 to 640 uM every 300 to 400 secs at pH 7 by isothermal titration calorimetry method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex assessed as melting temperature at 1:2 compound to DNA ratio at pH 7 by UV-visible spectrophotometer analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in absorption spectra at increasing concentration at pH 8 by UV-Vis spectra analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against erythromycin-sensitive Staphylococcus aureus ATCC 13709 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to Salmon sperm DNA assessed as increase in fluorescence at 0.8 uM by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by liquid scintillation counter","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Bacillus at 10 mg\/ml after 24 hrs by cut-plug method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Cell cycle arrest in human SK-BR-3 cells assessed as accumulation at G2\/M phase at 0.25 uM after 18 hrs using propidium iodide staining by FACS analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as melting temperature at 5 x 10'-6 M by thermal denaturation assay (Rvb = 68.4 degC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at 5 x 10'-6 M by thermal denaturation assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-ACCGGT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-ACACGT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of ethidium bromide from calf thymus DNA after 1 min by fluorimetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as fluorescence quenching by fluorescence spectroscopy analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of PI3K p110alpha E545K mutant using [gamma33P]ATP by filter binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human recombinant 5HT2C receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human S1P3 receptor expressed in CHO cells coexpressing Gq\/i5 G-protein assessed as Ca2+ mobilization after 60 to 90 mins by FLIPR assay relative to 1-(4-(6-benzylbenzofuran-2-yl)-3-fluorobenzyl)azetidine-3-carboxylic acid","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]CCPA from adenosine A1 receptor in rat brain cortical membrane","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-5-CT from human 5-HT7b receptor expressed in HEK293 cells after 1 hr","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to mGlu1 receptor in rat thalamus at 7.4 MBq after 60 mins by autoradiography","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Transactivation of GAL4-fused human PPARdelta ligand binding domain transfected in african green monkey COS7 cells by luciferase reporter gene assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against Tobacco mosaic virus (TMV) inoculated in whole leaves of Nicotiana tabacum L. assessed as curative effect measured as local lesion number at 50 mg\/l after 3 to 4 days","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells at 5 uM by TR-FRET based binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human adenosine A1 receptor by radioligand displacement assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human NCI-ADR-RES cells assessed as cell growth at 10'-5 M after 48 hrs by sulforhodamine B assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as intercalation after 2 hrs by UV-Vis absorption titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human recombinant SGK1 using ATP\/Ulight-RRRSLLE as substrate at 1 uM after 30 mins by LANCE assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at Pseudomonas aeruginosa PAO1 LasR expressing lasI coexpressing LVA-GFP at 100 to 200 uM after 24 hrs by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human VEGF165 C-terminal fragment of heparin binding domain (amino acid residues C137 to R165) expressed in T7 phage assessed as increase in emergence ratio of del4 T7 phage particles from host Escherichia coli BLT5615 cells by QCM sensorgram analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to M4 receptor (unknown origin) by PDSP assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human MDA-MB-231 cells assessed as cell growth at 10'-5 M after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of HSP90 (unknown origin) by luciferase refolding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli ribosomes after 2 hrs by fluorescence polarization assay in presence of BODIPY-labeled erythromycin A","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against erythromycin-susceptible Staphylococcus aureus by agar microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]spiperone from human D4.4 receptor stably expressed in CHO cell membranes by competitive binding assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Cytotoxicity against human A673 cells after 96 hrs by MTS assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Intrinsic activity at GAL4 tagged human PPARalpha ligand binding domain expressed in HEK293 cells at 1 uM by luciferase reporter gene assay relative to 1 uM GW2331","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimycobacterial activity against Mycobacterium sp.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by twofold dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]raclopride from dopamine D2 receptor in Sprague-Dawley rat striatal membranes after 30 mins","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect on LKB1 expression in mouse 3T3L1 cells at 0.2 mM after 10 mins, 2 and 24 hrs by western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human CNT2 expressed in African green monkey COS7 cells assessed as reduction of [14C]-inosine uptake at 100 uM by liquid scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potentiation of 2.5 nM (-)-lomaiviticin A-induced cytotoxicity against human K562 cells assessed as combination index at 10 uM after 48 hrs by cell titer-glo luminescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant CDK5\/p25 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated histone H1 as substrate after 1 hr by gamma32P-ATP based liquid scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human LOXIMVI cells incubated for 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MCF7 cells by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 4 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of biotinylated histone H3K14 peptide ligand from human recombinant His-tagged BRD4 bromodomain-1 measured after 10 mins by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HAX1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]BRL 43694 from human recombinant 5-HT3 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human MGC803 cells assessed as late apoptotic cells at 8 uM after 48 hrs Annexin V-FITC\/propidium iodide based flow cytometry (1%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative activity against human NCI-H2228 cells harboring EML4-ALK after 72 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length PRKCI (H215 to V587 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of Kinact to Ki for recombinant His6-tagged PAD1 (unknown origin) preincubated for 10 mins followed by BAEE substrate addition measured after 15 mins by COLDER assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length BMPR1A (Q214 to I532 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In-vivo binding affinity to transthyretin in beagle dog serum assessed as protein occupancy 5 mg\/kg\/day dosed daily dosed as single administration via oral gavage","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Candida albicans ATCC 90028 infected in Galleria mellonella larvae infected with 20 uM compound pre-treated cell suspensions assessed as melanization incubated in dark for 144 hrs at 30 degC and measured every 24 hrs (Rvb = 65%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to partial length human PAK2 (P151 to R525 residues) expressed in bacterial expression system by KINOMEscan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length PIKFYVE (F1512 to C2098 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of class 1 HDAC in human Cal27CisR cells assessed as potentiation of cisplatin-induced apoptosis by measuring increase in accumulation at sub-G1 phase at 5 uM preincubated for 48 hrs followed by cisplatin addition and measured after 24 hrs by propidium iodide staining based flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HCT116 cells assessed as viable cells at 0.5 uM by Annexin-V FITC\/propidium iodide staining-based flow cytometry (Rvb = 93.4 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human His-tagged TrkA catalytic domain (441 to 796 residues) expressed in baculovirus expression system using tyr 01 as substrate incubated for 1 hr by Z'-Lyte assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length GRK3 (M1 to L688 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human HCT116 cells afte r18 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human LSD1 (172 to 852 residues) using biotin-labelled H3K4me2 (1 to 24 residues) after 1 hr by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 2.5 uM after 12 hrs by Annexin V-FITC\/propidium iodide staining-based flow cytometric analysis (Rvb = 7.19%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of wild-type human partial length BLK (G211 to L503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length CHEK1 (M1 to G289 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length DMPK2 (S46 to S408 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length SBK1 (P23 to P348 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length SRPK1 (M1 to S655 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of cKIT (unknown origin) assessed as residual activity at 50 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus duplex DNA assessed as induction of ellipticity at 25 to 200 uM in pH 8.9 phosphate buffer by circular dichroism method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]diprenorphine from rat delta opioid receptor expressed in rat C6 cell membranes measured after 1 hr by liquid scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of croton oil-induced ear edema at 15 mg\/kg, ip administered 1 hr before croton oil challenge measured after 3 hrs post challenge relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human FXR expressed in human HuH7 cells by luciferase reporter gene assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of Ki for displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR in presence of GTP to Ki for displacement of [3H]DPCPX from Sprague-Dawley rat whole brain A1AR","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [125I]-NDP-alpha-MSH from human MC4R expressed in CHO-K1 cell membranes incubated for 3 hrs by top-count beta counting relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to c-myc G-quadruplex DNA (unknown origin) in PBS buffer (40 mM K+, pH 7.4) by spectrofluorimetric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA isolated from human A549 cells assessed as intercalating activity at 100 uM after 1 hr by electrophoretic mobility shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DAT (unknown origin) assessed as inhibition of ligand binding at 10 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HCC827 cells assessed as early apoptotic cells at 1 uM measured after 24 hrs by Annexin V-FITC\/propidium iodide staining based flow cytometry (Rvb = 2.49%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HPGDS (unknown origin) assessed as change in melting temperature by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of BRaf V600E mutant (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A-375 cells assessed as necrotic cells at 2 uM incubated for 48 hrs by annexin V-FITC and PI staining based flow cytometry (Rvb = 0.139 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of cell cycle arrest in human MDA-MB-231 cells assessed as accumulation at S phase at 4 uM incubated for 24 hrs by PI staining based flow cytometry analysis (Rvb = 40.37 to 57.89 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of RSK1 in human TE-10 cells assessed as suppression of P27KIP1 phosphorylation at 1 to 10 uM measured after 24 hrs by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of Miglitol Ki to test compound Ki for inhibition of jack bean alpha-mannosidase measured per DNJ unit","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative activity against human A498 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of ABCG2 (unknown origin) expressed in dog MDCK-II-BCRP cells assessed as Hoechst 33342 accumulation using Hoechst 33342 as substrate by microplate reader analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human RXR-alpha expressed in U2OS cells assessed as maximum relative efficacy at 100 uM by PathHunter assay relative to 9-cis-retinoic acid","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Covalent binding affinity to N-terminal His-Smt-tagged MSK1 C-terminal kinase domain (414 to 738 residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) at 1:1 ratio of enzyme to compound measured after 3 hrs by LC-MS analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to TCP-stimulated NMDA (unknown origin)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human Sirt3 (118 to 399 residues) assessed as dissociation constant (Koff) of ternary complex using acetylated MnSOD peptide as substrate in presence of OAADPr by short DNA nano levers based switchSENSE microfluid bio-chip analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
